Novel anti-inflammatory effects of doxazosin in rodent models of inflammation

Pharmacology

Volumn 91, Issue 1-2, 2013, Pages 29-34

  Tung, David ^a   Ciallella, John ^b   Cheung, Peter H ^a   Saha, Saurabh ^a  

^a BioMed Valley Discoveries   (United States)

^b Melior Discovery Inc   (United States)

Author keywords

1 Adrenergic receptor antagonist; Doxazosin; Inflammation

Indexed keywords

DOXAZOSIN; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; ALPHA ADRENERGIC RECEPTOR; DEXAMETHASONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DRUG EFFECT; FOOT EDEMA; FOOT PAD; HINDLIMB; HISTOPATHOLOGY; MALE; MONOCYTE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; DRUG POTENCY; EXPERIMENTAL PERITONITIS; INFLAMMATION; SWELLING;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DOXAZOSIN; ERYTHROCYTES; HYPERSENSITIVITY, DELAYED; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; PERITONITIS; SHEEP; THIOGLYCOLATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868607170     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000343762     Document Type: Article

References (26)

1. Graham RM: Adrenergic receptors: structure and function. Cleve Clin J Med 1990;57: 481-491.
2. Cotecchia S: The alpha1-adrenergic receptors: diversity of signaling networks and regulation. J Recept Signal Transduct Res 2010;30: 410-419.
3. Graham RM, Perez DM, Hwa J, Piascik MT: Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res 1996;78:737-749.
4. Wykretowicz A, Guzik P, Wysocki H: Doxa-zosin in the current treatment of hypertension. Expert Opin Pharmacother 2008;9: 625-633.
5. Roehrborn CG, Schwinn DA: Alpha1-adren-ergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 2004;171:1029-1035.
6. Lorton D, Lubahn C, Bellinger DL: Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr Drug Targets Inflamm Allergy 2003; 2:1-30.
7. Bergmann M, Sautner T: Immunomodula-tory effects of vasoactive catecholamines. Wien Klin Wochenschr 2002;114:752-761.
8. Rouppe van der Voort C, Kavelaars A, van de Pol M, Heijnen CJ: Neuroendocrine mediators up-regulate alpha1b-and alpha1d-ad-renergic receptor subtypes in human mono-cytes. J Neuroimmunol 1999;95:165-173.
9. Roupe van der Voort C, Heijnen CJ, Wulffraat N, Kuis W, Kavelaars A: Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory dis-ea se juveni le rheu matoid arthr it is: a putat ive role for alpha(1)-adrenergic receptors. J Neu-roimmunol 2000;110:223-229.
10. Trevisani M, Campi B, Gatti R, Andre E, Ma-terazzi S, Nicoletti P, et al: The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract. Eur Urol 2007;52: 901-908.
11. Heijnen CJ, Rouppe van der Voort C, Wul-ffraat N, van der Net J, Kuis W, Kavelaars A: Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular ju-ven i le rheu matoid ar thrit is. J Neuroim munol 1996;71:223-226.
12. Konig JE, Senge T, Allhoff EP, Konig W: Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate 2004;58:121-129.
13. Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, et al: Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 2002;52:43-58.
14. Shah US, Getzenberg RH: Fingerprinting the diseased prostate: associations between BPH and prostate cancer. J Cell Biochem 2004;91:161-169.
15. Theyer G, Kramer G, Assmann I, Sherwood E, Preinfalk W, Marberger M, et al: Pheno-typic characterization of infiltrating leukocytes in benign prostatic hyperplasia. Lab Invest 1992;66:96-107.
16. Derosa G, Cicero AF, D'Angelo A, Tinelli C, Ciccarelli L, Piccinni MN, et al: Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension. J Cardiovasc Pharmacol 2006;47: 508-512.
17. Fibbi B, Penna G, Morelli A, Adorini L, Mag-gi M: Chronic inflammation in the patho-genesis of benign prostatic hyperplasia. Int J Androl 2010;33:475-488.
18. Grisanti LA, Woster AP, Dahlman J, Sauter ER, Combs CK, Porter JE: Alpha1-adrener-gic receptors positively regulate Toll-like receptor cytokine production from human monocytes and macrophages. J Pharmacol Exp Ther 2011;338:648-657.
19. Bencsics A, Elenkov IJ, Vizi ES: Alpha 2-, alpha 2A-, alpha 2B/2C-adrenoceptor subtype antagonists prevent lipopolysaccharide-in-duced fever response in rabbits. Brain Res 1995;705:302-306.
20. Chiao CW, Lee SS, Wu CC, Su MJ: Thalipor-phine increases survival rate and attenuates multiple organ injury in LPS-induced endo-toxaemia. Naunyn Schmiedebergs Arch Pharmacol 2005;371:34-43.
21. Laengle UW, Trendelenburg AU, Markstein R, Nogues V, Provencher-Bollinger A, Roman D: GLC756 decreases TNF-alpha via an al-pha2 and beta2 adrenoceptor related mechanism. Exp Eye Res 2006;83:1246-1251.
22. Parissis JT, Korovesis S, Giazitzoglou E, Ka-livas P, Katritsis D: Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. Int J Cardiol 2002;83:13-21.
23. Chait A, Gilmore M, Kawamura M: Inhibition of low density lipoprotein oxidation in vitro by the 6-and 7-hydroxy-metabolites of doxazo-sin, an alpha 1-adrenergic antihypertensive agent. Am J Hypertens 1994;7:159-167.
24. Raij L, Hayakawa H, Coffee K, Guerra J: Effect of doxazosin on endothelial dysfunction in hypercholesterolemic/antioxidant-deficient rats. Am J Hypertens 1997;10:1257-1262.
25. Maestroni GJ: Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J Immunol 2000;165:6743-6747.
26. Brosnan CF, Goldmuntz EA, Cammer W, Factor SM, Bloom BR, Norton WT: Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune en-cephalomyelitis in the Lewis rat. Proc Natl Acad Sci USA 1985;82:5915-5919.